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Background. Juvenile idiopathic arthritis (JIA) is the most common form of rheumatic disease in childhood and adolescents,
affecting between 16 and 150 per 100,000 young persons below the age of 16. The lower limb is commonly affected in JIA, with
joint swelling and tenderness often observed as a result of active synovitis. Objective. The objective of this scoping review is to
identify the existence of physical examination (PE) tools to identify and record swollen and tender lower limb joints in children
with JIA. Methods. Two reviewers individually screened the eligibility of titles and abstracts retrieved from the following online
databases:MEDLINE, EMBASE, CochraneCentral Register of Controlled Trials, andCINAHL. Studies that proposed and validated
a comprehensive lower limb PE tool were included in this scoping review. Results. After removal of duplicates, 1232 citations
were retrieved, in which twelve were identified as potentially eligible. No studies met the set criteria for inclusion. Conclusion.
Further research is needed in developing and validating specific PE tools for clinicians such as podiatrists and other allied health
professionals involved in the management of pathological lower limb joints in children diagnosed with JIA. These lower limb PE
tools may be useful in conjunction with existing disease activity scores to optimise screening of the lower extremity andmonitoring
the efficacy of targeted interventions.
1. Background
Juvenile idiopathic arthritis (JIA) affects between 16 and 150
per 100,000 young persons below the age of 16 [1], with the
lower limb being commonly involved [2–5]. The hip, knee,
and ankle are the most commonly affected lower limb joints
in JIA, with prevalence rates of 30–50% across all subtypes
[3, 6, 7]. Approximately 40% of JIA patients will experience
rear foot (i.e., subtalar) joint synovitis [8], while the midfoot
(talonavicular and calcaneocuboid) and phalangeal joints
appear to be less affected [5]. The International League of
Associations for Rheumatology guideline for the diagnosis of
JIA relies on clinical examination and the number of joints
affected, forming part of the classification criteria [9]. Early
diagnosis and treatment are the gold-standard approach in
paediatric rheumatology [10]. However, evidence suggests
that there are significant delays in diagnosis [11–13], with a
recent study conducted in Australia reporting that more than
40% of children with JIA had a delay of 5 or more months
between onset of symptoms and diagnosis [13]. This delay in
diagnosis is likely to have a negative impact on the long-term
health outcomes in children with JIA [14].
Lower limb joint involvement in JIA consists of active
arthritis and joint damage. Swelling of foot and ankle joints,
particularly the rear foot and midfoot joints, may not be
clinically evident at disease onset and may present at a
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later stage as the disease flares or worsens. Moreover, sys-
temic pharmaceuticals and intracorticosteroid injections are
effective interventions in JIA but may not cause complete
remission of active arthritis in joints [1]. Prolonged active
arthritis may increase the risk of permanent joint damage,
such as cartilage erosion [15]. This may lead to increased
pain, impaired joint function, and higher rates of orthopaedic
intervention, such as joint arthroplasty [15, 16]. Two long-
term outcome studies in JIA, which include 328 participants
in total, have shown that the lower limb required more
surgical interventions than the upper limb [15, 17]. The most
commonly operated lower limb joints were the hip, knee, and
ankle [15, 17]. Identifying lower limb active arthritis earlier
and frequent screening may reduce the risk of irreversible
joint damage and the need for surgical intervention.
Recent evidence highlighted the potential limitations of
physical examination (PE) in JIA, with studies reporting that
medical imaging such as ultrasound and magnetic resonance
imaging may be more accurate in detecting active arthritis,
particularly subclinical disease [3, 7, 18–20]. Despite this
limitation, careful and routine PE remains gold standard
and an important assessment to detect early clinical changes
and prompt localised interventions. Paediatric rheumatol-
ogists conduct both upper and lower limb PE of joints
as part of their routine clinical assessment. Allied Health
Professionals (AHPs) such as podiatrists who focus solely
on the lower extremity may assist paediatric rheumatologists
in providing an additional screening of lower limb joints
using a standardised lower limb PE tool. This may allow
for a standardised and systematic method of screening the
lower extremity for early detection of active joint disease. It
may also enhance the ability of the paediatric rheumatology
team to detect active arthritis in more difficult to assess
joints such as the rear foot and midfoot joints of the feet.
Lower limb tools may resemble a manikin or tabular form,
depicting a focused count of swollen and tender lower limb
joints. Moreover, AHPs may also be involved in providing
localised, safe, noninvasive physical andmechanical therapies
that may implement patients’ current medical management.
For example, foot orthosesmay be prescribed to reduce lower
limb pain and improve quality of life [21, 22]. Finally, a PE
tool specific to the lower limb may enable clinicians and
researchers in allied health to test the effectiveness of localised
interventions in reducing swelling and tenderness of lower
extremity joints.
Scoping reviews may be used to search the literature to
thoroughly identify research gaps, provide summaries, and
justify the feasibility of conducting a future systematic review
[23]. This scoping review aims to identify the existence of
lower limb PE tools in detecting swollen and tender lower
limb joints in JIA.
2. Objective
Theobjective of this scoping review is to identify the existence
for PE tools thatmay be used to detect and record swollen and
tender lower limb joints in children with JIA.
3. Methods
According to Arksey and O’Malley (2005), a scoping review
is a comprehensive search of the evidence, which aims at
identifying existing gaps in the scientific literature [23]. A
scoping review can determine the value of undertaking a sys-
tematic review, whether it is feasible or not based on current
available literature, or if a systematic review has already been
conducted [23, 24]. Lastly, despitemethodological differences
between scoping and systematic reviews, scoping reviews
may summarise and disseminate key research findings [25].
For this paper, a scoping review was undertaken to explore
the literature on the existence of PE tools for the detection of
swollen and tender lower limb joints in children diagnosed
with JIA. A recently updated methodological framework for
scoping reviews published by Khalil et al. (2016) was adopted
[25].
3.1. Types of Studies Included
(i) Studies that involved designing or introducing a PE
protocol or tool for the identification of lower limb
joint swelling and tenderness in JIA were included in
this study.
(ii) Studies that involve disability tools were excluded.
Disability tools will measure the physical impact that
active arthritis has on lower limb joints. The purpose
of this scoping review is to identify standardised PE
tools that assist in the detection of active arthritis
rather than tools that measure physical disability.
3.2. Types of Physical Examination Tools
(i) PE tools that aid in identifying and recording swollen
and tender lower limb joints affected by active disease
in JIA were included.
(ii) Lower limb joints included in PE tools may contain
the hip, knee, ankle, subtalar (rear foot), talonavicular
and calcaneocuboid (midfoot), metatarsophalangeal
(forefoot), and proximal and distal interphalangeal
joints (digits).
(iii) Any design of the tool itself, which may contain a
manikin or tabular form, was also included.
(iv) Tools that consisted of an upper limb joint count were
excluded.
3.2.1. Searches. TheMEDLINE (January 1966 toAugust 2016)
search strategy is presented in Table 1. This search strategy
was adapted for EMBASE (January 1980 to August 2016),
Cochrane Central Register of Controlled Trials (CENTRAL)
(the Cochrane Library, latest issue), and CINAHL (from
1982). No language or publication restrictions were applied.
Reference lists of all included studies were checked for other
potentially eligible papers.
Two reviewers (Antoni Fellas and Andrea Coda) individ-
ually screened the titles and abstracts of all studies identified
by the search strategy. Full-text papers of potentially eligible
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Table 1: OvidSP MEDLINE search strategy.
(1) Juvenile idiopathic arthritis.mp. or Arthritis, Juvenile/
(2) Juvenile rheumatoid arthritis.mp.
(3) Juvenile chronic arthritis.mp.
(4) (1) or (2) or (3)
(5) exp Physical Examination/
(6) (joint∗ adj3 (exam∗ or assess∗)).mp.
(7) (5) or (6)
(8) (4) and (7)
studies were retrieved by Antoni Fellas and individually
screened by Antoni Fellas and Andrea Coda. If the two
reviewers (Antoni Fellas and Andrea Coda) did not resolve
disputes successfully, a third reviewer (Derek Santos) would
act as an arbitrator to resolve any disagreements, though this
was never required.
3.2.2. Data Extraction/Charting. As no studies were included
in this scoping review, a full data extraction was not con-
ducted. Extraction of information from included studies was
to be as follows: author(s), year of publication, country of ori-
gin, aims, study population, sample size, methodology, type
of PE tool, type of comparator (if applicable), how outcomes
aremeasured, and key findings. To assist in the interpretation
of results, basic descriptive information of potentially eligible
studies was obtained and presented in Table 2. Charting the
data in this paper included a combination of narrative style
writing and the presentation of a summary table.
4. Results
4.1. Description of Studies
4.1.1. Studies Identified. After the removal of duplicates, 1232
studies were retrieved from the search (Figure 1). Twelve
potentially eligible papers were identified after titles and
abstracts were screened, for which full texts were retrieved
[26–37]. One paper was immediately excluded as it was a
conference abstract of an already included paper [37]. Seven
papers were excluded as they involved an upper limb joint
count in either an overall global disease activity score or PE
tool [27–29, 31, 32, 35, 36]. One study was excluded, as it was
a review article [30]. Antoni Fellas screened all references for
additional suitable PE tools; however, no additional papers
were retrieved. Two potentially eligible studies compared
clinical examination to ultrasound in the identification of
pathological joints in JIA [33, 35]. The objective of these
studies was not to develop or validate a lower limb PE tool;
therefore, they were excluded. One more study was excluded
as it was not relevant [34]. Basic data on the potentially
eligible papers are outlined in Table 2.
4.2. Juvenile Arthritis Foot Disability Index. Only one study
identified as potentially eligible was specific to the lower
limb [26]. The authors of the study developed a foot and
ankle disability index for JIA, called the juvenile arthritis foot
disability index (JAFI). The JAFI measures foot and ankle
disability using 27 consecutive questions regarding the effects
of arthritis on their physical impairment, activity limitation,
and participation restriction. The authors concluded that the
JAFI is a valid and reliablemeasure of foot and ankle disability
in children and adolescents with JIA [26]. Overall, the design
and the purpose of the study were not to validate a PE tool
for lower limb joint swelling and tenderness in JIA. Thus, the
study does not fit the inclusion criteria for this scoping review
and was ultimately excluded.
4.3. Summary of Existing Tools. This section will summarise
how the lower limb was assessed in those studies listed as
potentially eligible and relevant.
(i) Two studies used a 69-joint, full bodymanikin includ-
ing joints from both upper and lower limbs [27, 32].
The 69-joint count included the hip, knee, ankle,
metatarsophalangeal joints, and phalanges of the feet
but not the subtalar and midfoot joints and did not
distinguish between distal and proximal phalangeal
joints.The 69-joint manikin was designed to test joint
examination by patients and parents of active disease
in JIA and compare their assessments to paediatric
rheumatologists’ assessments [27]. This may account
for why more difficult clinical examinations (such as
the rear foot and midfoot joints) were excluded.
(ii) A 67-joint count was used by one study to develop
weighted scores in JIA [28]. The type of PE tool was
unclear and the study did not include the subtalar and
midfoot joints and did not distinguish between distal
and proximal phalangeal joints [28].
(iii) One study aimed to develop and test reduced joint
counts. Four different reduced joint counts were
tested, in which all of them did not include the
subtalar, midfoot, and interphalangeal joints [29]. It
was also unclear what type of PE tool was used.
(iv) One study aimed to develop and validate joint dam-
age in JIA [36]. Part of the index included clinical
range of motion testing for the hip, knee, ankle, and
metatarsophalangeal joints, as well as scores for fixed
flexion deformities thatmay ormay not have required
surgical intervention [36]. The subtalar, midfoot, and
phalangeal joints were not included in this joint
damage index.
(v) Lastly, one study aimed to develop and validate a
composite score for JIA called the Juvenile Arthritis
Disease Activity Score (JADAS) [31]. Part of this
composite score included simple joint counts for
active disease of varying number. The 71-joint count
included the largest number of joints covered in both
upper and lower extremities. The JADAS-71 includes
all lower limb joints except the distal and proximal
phalangeal joints, and it is unclearwhatmidfoot joints
were included [31].
Overall, these studies did not include the rear foot and
midfoot joints, aswell as distal and proximal phalangeal joints
4 Arthritis
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Figure 1: PRISMA flow diagram.
in their joint assessments or PE tools. The outcome of this
finding needs to be taken into context with the aims of the
studies outlined in this section. For example,majority of these
studies focused on developing and validating reduced joint
counts or disease composite scores; thus the exclusion of
certain lower limb joints, particularly in the feet, was prudent.
The authors of one study concluded that, despite the exclusion
of joints such as the subtalar and midfoot joints, it does not
deter the importance of screening them for active disease
[28].
5. Discussion
The results of this scoping review have indicated paucity
in the current literature for a validated PE tool in the
assessment of lower limb joint swelling and tenderness. Seven
potentially eligible papers were excluded from this review as
they involved an upper limb count of swollen and tender
joints [27–29, 31, 32, 36]. Consolaro et al. (2009) developed
the composite disease activity score in JIA, the JADAS [31].
This extensively validated tool is used in children with JIA,
representing the most widely recognised and accepted global
activity scale in paediatric rheumatology.The JADAS is com-
monly used to record global disease changes, which includes
varying counts of upper and lower swollen and tender (active)
joints [31, 38]. Certain physical and mechanical therapies
such as foot orthoses target specific areas of the body (i.e., the
lower limb only) and they are not prescribed as a stand-alone
intervention to impact on overall disease activity. Therefore,
the JADAS may not be suitable in effectively measuring the
impact that therapies such as foot orthoses have on the lower
limb joint swelling and tenderness.Helliwell (2007) suggested
a PE tool for swollen and tender foot and ankle joints for
adult rheumatoid arthritis [39]. The proposed PE tool is a 14-
joint count (28 bilaterally), which includes the ankle, subta-
lar, talonavicular, calcaneocuboid, metatarsophalangeal, and
interphalangeal joints [39]. A modified version of this tool,
which also includes the hip, knee, and distal and proximal
interphalangeal joints, may be appropriate for establishing
the reliability and validity in future studies.
This scoping review focused on PE as a diagnostic tool
to identify swollen and tender lower limb joints in JIA.
Upper limb joint counts were excluded in this review as the
6 Arthritis
objective of our research was to identify validated lower limb
PE tools, which may be used for future clinical research,
focusing on physical and/or mechanical therapies for lower
extremity problems in JIA. Moreover, a review to identify
the existence of upper limb PE tools may be of benefit for
those focusing on therapies targeting upper limb problems
only in JIA. A limitation of this scoping review is that joint
damage and musculoskeletal problems secondary to active
arthritis were not considered in this study but, neverthe-
less, are important clinical problems to screen in JIA. The
paediatric gait, arms, legs, and spine (pGALS) is a validated
screening tool in paediatrics and can be used by paedi-
atric rheumatologists to identify joint and musculoskeletal
abnormalities in children with JIA [40]. Finally, this scoping
review revealed that currently there are no eligible studies
according to our inclusion criteria. These findings justify
even further that a systematic review may not have been
feasible for this specific research question. Further research in
designing and validating optimal lower limb PE tools in JIA is
needed.
Future studiesmay focus on testing validity and reliability
(intra- and interrater) of a lower limb PE tool compared
to a sensitive imaging modality such as magnetic resonance
imaging.These easily accessible tools can be utilised byAHPs,
as part of the daily clinical assessment, accompanied by
additional validated measures, such as the pGALS or JADAS.
This may promote the early detection of both active disease
and musculoskeletal problems in the lower extremity with
children suffering from JIA. Lastly, validated and reliable PE
tools specific to the lower limb may be useful for researchers
investigating the efficacy of therapies for the lower extremity
in JIA.
6. Conclusion
This scoping review did not identify any validated PE tools
for the count of swollen and tender lower limb joints in
JIA. Further research may aim to develop and validate future
lower limb PE tools, which may be used in combination with
other validated measures of disease activity in a multidisci-
plinary approach to detect lower limb joint disease.Moreover,
clinicians specialising in the lower limb such as podiatrists
and other AHPs may find a validated tool useful to monitor
the progress of targeted interventions.
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